(R)-1-(3-trifluoromethyl-benzyl)-5-oxo-pyrrolidine-2-carboxylic acid | 1254699-72-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (R)-1-(3-trifluoromethyl-benzyl)-5-oxo-pyrrolidine-2-carboxylic acid
• 英文别名: (2R)-5-oxo-1-[[3-(trifluoromethyl)phenyl]methyl]pyrrolidine-2-carboxylic acid
• CAS: 1254699-72-3
• 化学式: C₁₃H₁₂F₃NO₃
• 分子量: 287.238
• InChiKey: BKDONIRKXQOOQE-SNVBAGLBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  57.6
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  (R)-1-(3-trifluoromethyl-benzyl)-5-oxo-pyrrolidine-2-carboxylic acid 、 3-氨基-2-羟基-4-苯丁酰胺 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 N,N-二异丙基乙胺 作用下， 生成
  参考文献：
  名称：

  Discovery of ABT-957: 1-Benzyl-5-oxopyrrolidine-2-carboxamides as selective calpain inhibitors with enhanced metabolic stability

  摘要：

  Aberrant activation of calpain has been observed in various pathophysiological disorders including neurode-generative diseases such as Alzheimer's Disease. Here we describe our efforts on ketoamide-based 1-benzyl-5-oxopyrrolidine-2-carboxamides as a novel series of highly selective calpain inhibitors mitigating the metabolic liability of carbonyl reduction. The most advanced compound from this new series, namely A-1212805 (ABT-957, Alicapistat) proceeded to clinical phase I studies.

  DOI：

  10.1016/j.bmcl.2019.05.034

文献信息

• Carboxamide compounds and their use as calpain inhibitors
  申请人：Abbott Laboratories

  公开号：US08283363B2

  公开（公告）日：2012-10-09

  The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula I in which R1, R2, R3a, R3b, R4, Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula Ia and Ib in which R1, r, R2b, R3a, R3b, R4, Y and X have the meanings mentioned in the claims, including the tautomers thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein Y is a moiety CH2—CH2, CH2—CH2—CH2, N(Ry#)—CH2, N(Ry#)—CH2—CH2 or CH═CH—CH═, each optionally having 1 or 2 H-atoms replaced with identical or different radicals Ry, wherein Ry and Ry# have the meanings mentioned in the claims.

  本发明涉及新型羧酰胺化合物及其用于制造药物的用途。这些羧酰胺化合物是钙依赖性半胱氨酸蛋白酶（calpain）的抑制剂。因此，本发明还涉及使用这些羧酰胺化合物治疗与升高的calpain活性相关的疾病。这些羧酰胺化合物是通式I的化合物，其中R1、R2、R3a、R3b、R4、Q、Y、A和X具有权利要求和说明书中提到的含义，它们的互变异构体和药学上适用的盐。特别是，这些化合物具有通式Ia和Ib，其中R1、r、R2b、R3a、R3b、R4、Y和X具有权利要求中提到的含义，包括它们的互变异构体和药学上适用的盐。其中，首选Y是一个基团CH2-CH2、CH2-CH2-CH2、N（Ry#）-CH2、N（Ry#）-CH2-CH2或CH═CH-CH═，每个基团可选地用1或2个H原子替换为相同或不同的基团Ry，其中Ry和Ry#具有权利要求中提到的含义。
• CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS
  申请人：Mack Helmut

  公开号：US20110086879A1

  公开（公告）日：2011-04-14

  The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula I in which R 1 , R 2 , R 3a , R 3b , R 4 , Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula Ia and Ib in which R 1 , r, R 2b , R 3a , R 3b , R 4 , Y and X have the meanings mentioned in the claims, including the tautomers thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein Y is a moiety CH 2 —CH 2 , CH 2 —CH 2 —CH 2 , N(R y# )—CH 2 , N(R y# )—CH 2 —CH 2 or CH═CH—CH═, each optionally having 1 or 2 H-atoms replaced with identical or different radicals R y , wherein R y and R y# have the meanings mentioned in the claims.

  本发明涉及新型羧酰胺化合物及其用于制备药物的用途。这些羧酰胺化合物是钙依赖性半胱氨酸蛋白酶（calpain）的抑制剂。因此，本发明还涉及使用这些羧酰胺化合物治疗与升高的calpain活性相关的疾病。这些羧酰胺化合物是通式I的化合物，其中R1、R2、R3a、R3b、R4、Q、Y、A和X具有所述权利要求和说明书中提到的含义，它们的互变异构体和药学上适用的盐。特别是，化合物具有通式Ia和Ib，其中R1、r、R2b、R3a、R3b、R4、Y和X具有所述权利要求中提到的含义，包括其互变异构体和药学上适用的盐。其中，首选Y是CH2-CH2、CH2-CH2-CH2、N（Ry#）-CH2、N（Ry#）-CH2-CH2或CH=CH-CH=的基团，每个基团可选择性地用相同或不同的基团Ry替换1或2个氢原子，其中Ry和Ry#具有所述权利要求中提到的含义。
• US8236798B2
  申请人：——

  公开号：US8236798B2

  公开（公告）日：2012-08-07
• US8283363B2
  申请人：——

  公开号：US8283363B2

  公开（公告）日：2012-10-09
• US9018206B2
  申请人：——

  公开号：US9018206B2

  公开（公告）日：2015-04-28